Introduction
Administration of exogenous gonadotrophins to female mammals causes superovulation, which is used as a routine procedure for producing greater yields of embryos in develop¬ mental and genetic studies. However, compared with sponta¬ neous ovulation, superovulation is associated with a greater loss of embryos during pregnancy (Allen and McLaren, 1971; Beaumont and Smith, 1975; Miller and Armstrong, 1982; Walton et al, 1983) .
The mechanisms by which gonadotrophins increase the incidence of abnormal ova are unclear, but some suggestions have been made. Degenerative changes occur in some ova as a result of fertilization failure (Walton et al, 1983; Evans and Armstrong, 1984) , possibly owing to an imbalance in the concentrations of oestradiol and progesterone (Miller and Armstrong, 1981, 1982; Jutaro et al, 1982) . Injections of pregnant mares' serum gonadotrophin (PMSG) result in the appearance of a number of cumulus-free oocytes. Any abnor¬ mality of cumulus-free oocytes could result from ageing, as they had presumably ovulated in response to LH present in the injected PMSG (Murphy et al, 1984) . These prematurely ovulated eggs would be too old to be fertilized (Gates, 1971) .
Moreover, it has been shown that treatment with gonado¬ trophins produces genetic defects in the ova in viva (Luckett and Mukherjee, 1986) and in vitro (Maudlin and Frazer, 1977) .
However, the incidence of atresia among antral follicles is significantly reduced after injection of PMSG. Two hypotheses have been suggested: PMSG either prevents some normal follicles becoming atretic or it rescues some atretic follicles so that they revert to a normal state (Peters et al, 1975; Braw and Tsafriri, 1980; Moniaux et al, 1984 (Beaumont and Smith, 1975 (Brinster, 1971 (Goto et al, 1987) or to a different responsiveness of the ovaries to exogenous gonado¬ trophins (Spearow, 1988a, b) , which could influence the number of eggs superovulated.
In agreement with previous studies (Edwards et al, 1963) Kawashima, 1982) . Their growth rate is not significantly influenced by the stage in the oestrous cycle (Pedersen, 1970) . Presumably, the total number of these competent follicles present in the ovary of the treated females could determine the total number of eggs superovulated.
Two groups of oocytes (cumulus-free and cumulus-enclosed) were present after PMSG injection at all stages of the oestrous cycle in DD mice. Fragmented, cumulus-free oocytes could result from ageing, as they had presumably been ovulated because of an LH-like effect of PMSG (Gates, 1971) . Fully developed follicles are present in late pro-oestrus in mouse and rat ovaries (Pedersen, 1970; Richards, 1978) , which may explain why we observed a higher proportion of cumulus-free oocytes after an injection of PMSG during pro-oestrus.
The different morphology of cumulus-enclosed oocytes showed that oocytes at different developmental stages (i.e. at different ages) could be induced to ovulate. The age of an oocyte is known to be of great importance for its developmen¬ tal capacity (Martin and Terranova, 1982) . The ageing of oocytes leads to a decreased fertilization rate (Evans and Armstrong, 1984) , to an increased incidence of polyspermy (Odor and Blandau, 1956) , to changes in some organelles (Bedford, 1971) and to a decreased RNA concentration in oocytes (Bogomolova et al, 1981 (Eppig et al, 1992) . Eppig and Schroeder (1989) (Bedford, 1971 (Gates, 1971) ; that is, competent oocytes ovulate 59-61 h after PMSG injection. However, under normal conditions preantral follicles develop to ovulating follicles within two cycles (Numazawa and Kawashima, 1982 Beaumont and Smith (1975) , who found that 44% of ova were lost before implantation after inducing superovulation with exogenous PMSG at dioestrus. In rodents, the pool of committed growing follicles is greatest at oestrus as a result of the pro-oestrus surge of endogenous FSH (Pedersen, 1970; Richards, 1978 
